机译:ERBB2 EXON 20临床表征ERBB2 EXON 20在中国肺癌中的成果的插入和异质性
Department of Oncology General Hospital of Chinese PLA;
Department of Oncology General Hospital of Chinese PLA;
Department of Thoracic Medical Oncology Hunan Cancer Hospital/the Affiliated Cancer Hospital of;
Department of Oncology Hunan Cancer Hospital;
Department of Radiotherapy Provincial Hospital Affiliated To Shandong University;
State Key Laboratory of Respiratory Disease guangzhou Institute of Respiratory Disease The First;
Department of Respiratory Medicine Xiangya Hospital Central South University;
Department of Thoracic Surgery Peking University Shenzhen Hospital;
Department of Thoracic Surgery Ningbo No. 2 Hospital;
Department of Respiratory Zhongshan Hospital Affiliated with Fudan University;
Department of Oncology General Hospital of Chinese PLA;
Burning Rock Biotech;
Burning Rock Biotech;
Burning Rock Biotech;
Burning Rock Biotech;
Burning Rock Biotech;
机译:ERBB2 EXON 20临床表征ERBB2 EXON 20在中国肺癌中的成果的插入和异质性
机译:脉冲afatinib用于erbb2外显子20插入突变的肺腺癌
机译:EGFR外显子20插入中华高级非小型细胞肺癌患者的突变:全国性研究的分子异质性和治疗结果
机译:使用基于投影的结节插入来确定放射科医生阅读器在肺癌筛查CT中的表现的虚拟临床试验
机译:早期非小细胞肺癌临床结果的预处理辐射瘤模型(NSCLC)
机译:中国肺癌患者ERBB2外显子20插入的临床特征和对阿法替尼的预后异质性
机译: erbb2 em>外显子20的临床表征及其在中国肺癌患者中AMATINIB的结果的插入及异质性